Literature DB >> 19887927

A review of the effectiveness of antimitotic drug injections for hypertrophic scars and keloids.

Xi-Qiao Wang1, Ying-Kai Liu, Chun Qing, Shu-Liang Lu.   

Abstract

Hypertrophic scars and keloids are common problems after injury and cause functional and cosmetic deformities. A wide variety of treatments have been advocated for hypertrophic scars and keloids regression. Unfortunately, the reported efficacy has been variable. This article explores antimitotic drugs described in the literature such as steroid injection, 5-FU, mitomycin C, and bleomycin, which mainly target the fibroblasts in scar tissue, have been proposed as the effective modalities for scar treatment and scar prevention after surgery, but restricted due to possible side effects. The current accepted treatment for hypertrophic scar and keloid are combination therapy and the early treatment which could achieve better efficacy and less adverse effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887927     DOI: 10.1097/SAP.0b013e3181978753

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  17 in total

1.  Identification of a neuronal gene expression signature: role of cell cycle arrest in murine neuronal differentiation in vitro.

Authors:  Hady Felfly; Jin Xue; Alexander C Zambon; Alysson Muotri; Dan Zhou; Gabriel G Haddad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 2.  Scar Management of the Burned Hand.

Authors:  Michael Sorkin; David Cholok; Benjamin Levi
Journal:  Hand Clin       Date:  2017-02-20       Impact factor: 1.907

3.  Role of verapamil in preventing and treating hypertrophic scars and keloids.

Authors:  Ru Wang; Yu Mao; Zhenyu Zhang; Zhengyong Li; Junjie Chen; Ying Cen
Journal:  Int Wound J       Date:  2015-05-12       Impact factor: 3.315

4.  Comparison of Intralesional Triamcinolone Acetonide, 5-Fluorouracil, and Their Combination for the Treatment of Keloids.

Authors:  Sunil Srivastava; Aditya Nanasaheb Patil; Chaitra Prakash; Hiranmayi Kumari
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-11-01       Impact factor: 4.730

5.  Combined effects of long-pulsed neodymium-yttrium-aluminum-garnet laser, diprospan and 5-fluorouracil in the treatment of keloid scars.

Authors:  Xiao-E Chen; Juan Liu; Afzaal Ahmed Bin Jameel; Maya Valeska; Jia-An Zhang; Yang Xu; Xing-Wu Liu; Hong Zhou; Dan Luo; Bing-Rong Zhou
Journal:  Exp Ther Med       Date:  2017-05-08       Impact factor: 2.447

6.  Engineering and characterization of the chimeric antibody that targets the C-terminal telopeptide of the α2 chain of human collagen I: a next step in the quest to reduce localized fibrosis.

Authors:  Jolanta Fertala; Andrzej Steplewski; James Kostas; Pedro Beredjiklian; Gerard Williams; William Arnold; Joseph Abboud; Anshul Bhardwaj; Cheryl Hou; Andrzej Fertala
Journal:  Connect Tissue Res       Date:  2013-04-15       Impact factor: 3.417

7.  Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures.

Authors:  Yuhsin Wu; Steve J Schomisch; Cassandra Cipriano; Amitabh Chak; Richard H Lash; Jeffrey L Ponsky; Jeffrey M Marks
Journal:  Surg Endosc       Date:  2013-10-08       Impact factor: 4.584

Review 8.  Heterotopic Ossification and Hypertrophic Scars.

Authors:  Shailesh Agarwal; Michael Sorkin; Benjamin Levi
Journal:  Clin Plast Surg       Date:  2017-07-10       Impact factor: 2.017

Review 9.  Recent developments in the use of intralesional injections keloid treatment.

Authors:  Aurelia Trisliana Perdanasari; Davide Lazzeri; Weijie Su; Wenjing Xi; Zhang Zheng; Li Ke; Peiru Min; Shaoqing Feng; Yi Xin Zhang; Paolo Persichetti
Journal:  Arch Plast Surg       Date:  2014-11-03

Review 10.  The Use of Chemotherapeutics for the Treatment of Keloid Scars.

Authors:  Christopher David Jones; Luke Guiot; Mike Samy; Mark Gorman; Hamid Tehrani
Journal:  Dermatol Reports       Date:  2015-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.